Table 1 Baseline Participant Characteristics
|  | All (N = 30) | HIIT group (N = 15) | CON Group (N = 15) |
|---|---|---|---|
Age, years, mean (SD) | 46.9 (9.8) | 49.1 (7.9) | 44.7 (11.2) |
Menopausal status | |||
 Premenopausal | 11 (37) | 5 (33) | 6 (40) |
 Postmenopausal | 19 (63) | 10 (67) | 9 (60) |
Body Weight, kg, mean (SD) | 77.7 (18.3) | 80.9 (17.7) | 74.5 (18.8) |
Height, cm, mean (SD) | 158.4 (8.2) | 156.5 (6.6) | 160.3 (9.9) |
BMI, kg/m2, mean (SD) | 31.6 (7.7) | 33.1 (7.6) | 30.1 (7.7) |
Race/ethnicity | |||
 Non-Hispanic white | 4 (13) | 3 (20) | 1 (6) |
 Hispanic white | 22 (73) | 11 (74) | 11 (74) |
 African American | 2 (7) | 0 (0) | 2 (14) |
 Asian/Pacific Islander | 2 (7) | 1 (6) | 1 (6) |
Disease stage | |||
 I | 2 (7) | 1 (6) | 1 (6) |
 II | 9 (30) | 5 (30) | 4 (24) |
 III | 19 (63) | 9 (64) | 10 (70) |
Chemotherapy | |||
 Neoadjuvant | 23 (77) | 11 (73) | 12 (80) |
 Adjuvant | 7 (23) | 4 (27) | 3 (20) |
International physical activity questionnaire (MET min per week of moderate to vigorous intensity recreational activity), mean (SD) | 462.5 (101.2) | 480.9 (85.3) | 441.9 (93.2) |